PATENT CLAIM ANALYSIS

Application Number: 16069049
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["514", "225800"]

Abstract:
The present invention relates to compounds of the following general formula (I) or (II): or a pharmaceutically acceptable salt and/or solvate thereof, for use in the treatment and/or in the prevention of ErbB2 dependent cancers, and pharmaceutical compositions containing such compounds.

Claim (Index 2):
The method according to  claim 1 , wherein R 1  is hydrogen atom, halo, \u2014CN, \u2014NO 2 , \u2014NO, \u2014CHO, \u2014NR 7 R 8 , \u2014CO 2 R 9 , \u2014SO 2 R 10 , \u2014SO 2 NR 11 R 12 , \u2014COR 14 , \u2014CONR 16 R 17 , \u2014SO 2 (O)R 18  or a group selected from saturated (C 1 -C 6 )alkyl, unsaturated (C 1 -C 6 )alkyl and aryl, said group being optionally substituted with one or several groups selected from halo, \u2014CF 3 , \u2014CN and \u2014SO 2 NR 19 R 20 ; R 7  to R 12 , R 14  and R 16  to R 20  being as defined in  claim 1 .

Metadata:
- Claim Count in Document: 2.0
- Percentile: 95.0
- Lexical Diversity: 1.25641
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15768388', '13497924', '15023159', '14385808', '15768257']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7336305882098149
- 35 USC 102 Novelty (BERT): 0.5124553316878723
- Combined Prediction Score: 0.7115130625576206
- Mean Citation Score: 268.27641
- Max Citation Score: 282.37735
- Similarity Product: 229.32635262174904

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test